Skip to main content
SpringerLink
Log in

The Genetics of Cerebral Aneurysms and Other Vascular Malformations

  • Chapter
  • First Online:
Stroke Genetics

  • 36 Accesses

Abstract

Vascular malformations and aneurysms that may affect the blood vessels in the brain include developmental venous anomalies, intracranial saccular aneurysms, arteriovenous malformations, capillary telangiectasias, and cavernous malformations. These lesions are increasingly detected due to the frequency of cross-sectional brain imaging. While some of these lesions are benign, others can be associated with neurological symptoms and intracranial hemorrhage. As molecular biological techniques continue to advance there is rapidly evolving information regarding the genetics of intracranial aneurysms and vascular malformations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Menghini VV, Brown RD Jr, Sicks JD, O’Fallon WM, Wiebers DO. Incidence and prevalence of intracranial aneurysms and hemorrhage in Olmsted County, Minnesota, 1965 to 1995. Neurology. 1998;51(2):405–11.

    Article  CAS  PubMed  Google Scholar 

  2. Linn FH, Rinkel GJ, Algra A, van Gijn J. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke. 1996;27(4):625–9.

    Article  CAS  PubMed  Google Scholar 

  3. Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 1998;29(1):251–6.

    Article  CAS  PubMed  Google Scholar 

  4. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006;355(9):928–39.

    Article  CAS  PubMed  Google Scholar 

  5. Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol. 2011;10(7):626–36.

    Article  PubMed  Google Scholar 

  6. Longstreth WT Jr, Koepsell TD, Yerby MS, van Belle G. Risk factors for subarachnoid hemorrhage. Stroke. 1985;16(3):377–85.

    Article  PubMed  Google Scholar 

  7. Juvela S. Prevalence of risk factors in spontaneous intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage. Arch Neurol. 1996;53(8):734–40.

    Article  CAS  PubMed  Google Scholar 

  8. Kissela BM, Sauerbeck L, Woo D, Khoury J, Carrozzella J, Pancioli A, et al. Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke. 2002;33(5):1321–6.

    Article  PubMed  Google Scholar 

  9. Sankai T, Iso H, Shimamoto T, Kitamura A, Naito Y, Sato S, et al. Prospective study on alcohol intake and risk of subarachnoid hemorrhage among Japanese men and women. Alcohol Clin Exp Res. 2000;24(3):386–9.

    Article  CAS  PubMed  Google Scholar 

  10. Donahue RP, Abbott RD, Reed DM, Yano K. Alcohol and hemorrhagic stroke. The Honolulu Heart Program. JAMA. 1986;255(17):2311–4.

    Article  CAS  PubMed  Google Scholar 

  11. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78(12):1365–72.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Broderick JP, Brott T, Tomsick T, Huster G, Miller R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med. 1992;326(11):733–6.

    Article  CAS  PubMed  Google Scholar 

  13. Foroud T, Sauerbeck L, Brown R, Anderson C, Woo D, Kleindorfer D, et al. Genome screen to detect linkage to intracranial aneurysm susceptibility genes: the Familial Intracranial Aneurysm (FIA) study. Stroke. 2008;39(5):1434–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Low SK, Takahashi A, Cha PC, Zembutsu H, Kamatani N, Kubo M, et al. Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA. Hum Mol Genet. 2012;21(9):2102–10.

    Article  CAS  PubMed  Google Scholar 

  15. Foroud T, Koller DL, Lai D, Sauerbeck L, Anderson C, Ko N, et al. Genome-wide association study of intracranial aneurysms confirms role of ANRIL and SOX17 in disease risk. Stroke. 2012;43(11):2846–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Alg VS, Sofat R, Houlden H, Werring DJ. Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals. Neurology. 2013;80(23):2154–65.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Bakker MK, van der Spek RAA, van Rheenen W, Morel S, Bourcier R, Hostettler IC, et al. Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors. Nat Genet. 2020;52(12):1303–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Foroud T, Lai D, Koller D, Van’t Hof F, Kurki MI, Anderson CS, et al. Genome-wide association study of intracranial aneurysm identifies a new association on chromosome 7. Stroke. 2014;45(11):3194–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Yasuno K, Bilguvar K, Bijlenga P, Low SK, Krischek B, Auburger G, et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet. 2010;42(5):420–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Bakker MK, Ruigrok YM. Genetics of intracranial aneurysms. Stroke. 2021;52(9):3004–12.

    Article  PubMed  Google Scholar 

  21. Schievink WI, Schaid DJ, Michels VV, Piepgras DG. Familial aneurysmal subarachnoid hemorrhage: a community-based study. J Neurosurg. 1995;83(3):426–9.

    Article  CAS  PubMed  Google Scholar 

  22. De Braekeleer M, Perusse L, Cantin L, Bouchard JM, Mathieu J. A study of inbreeding and kinship in intracranial aneurysms in the Saguenay Lac-Saint-Jean region (Quebec, Canada). Ann Hum Genet. 1996;60(Pt 2):99–104.

    Article  PubMed  Google Scholar 

  23. Ronkainen A, Hernesniemi J, Puranen M, Niemitukia L, Vanninen R, Ryynanen M, et al. Familial intracranial aneurysms. Lancet. 1997;349(9049):380–4.

    Article  CAS  PubMed  Google Scholar 

  24. Raaymakers TW. Aneurysms in relatives of patients with subarachnoid hemorrhage: frequency and risk factors. MARS Study Group. Magnetic resonance angiography in relatives of patients with subarachnoid hemorrhage. Neurology. 1999;53(5):982–8.

    Article  CAS  PubMed  Google Scholar 

  25. Broderick JP, Brown RD Jr, Sauerbeck L, Hornung R, Huston J III, Woo D, et al. Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms. Stroke. 2009;40(6):1952–7.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Wiebers DO, Whisnant JP, Huston J III, Meissner I, Brown RD Jr, Piepgras DG, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362(9378):103–10.

    Article  PubMed  Google Scholar 

  27. Woo D, Khoury J, Haverbusch MM, Sekar P, Flaherty ML, Kleindorfer DO, et al. Smoking and family history and risk of aneurysmal subarachnoid hemorrhage. Neurology. 2009;72(1):69–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Thompson BG, Brown RD Jr, Amin-Hanjani S, Broderick JP, Cockroft KM, Connolly ES Jr, et al. Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(8):2368–400.

    Article  PubMed  Google Scholar 

  29. Nurmonen HJ, Huttunen T, Huttunen J, Kurki MI, Helin K, Koivisto T, et al. Polycystic kidney disease among 4,436 intracranial aneurysm patients from a defined population. Neurology. 2017;89(18):1852–9.

    Article  PubMed  Google Scholar 

  30. Zhou Z, Xu Y, Delcourt C, Shan J, Li Q, Xu J, et al. Is regular screening for intracranial aneurysm necessary in patients with autosomal dominant polycystic kidney disease? A systematic review and meta-analysis. Cerebrovasc Dis. 2017;44(1–2):75–82.

    Article  PubMed  Google Scholar 

  31. Perrone RD, Malek AM, Watnick T. Vascular complications in autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2015;11(10):589–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Rossetti S, Harris PC. The genetics of vascular complications in autosomal dominant polycystic kidney disease (ADPKD). Curr Hypertens Rev. 2013;9(1):37–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Irazabal MV, Huston J III, Kubly V, Rossetti S, Sundsbak JL, Hogan MC, et al. Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011;6(6):1274–85.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Rozenfeld MN, Ansari SA, Shaibani A, Russell EJ, Mohan P, Hurley MC. Should patients with autosomal dominant polycystic kidney disease be screened for cerebral aneurysms? AJNR Am J Neuroradiol. 2014;35(1):3–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998;13(12):624–8.

    Article  CAS  PubMed  Google Scholar 

  36. Chen YL, Luo CB, Hsu SW, Rodesch G, Lasjaunias P. Tuberous sclerosis complex with an unruptured intracranial aneurysm: manifestations of contiguous gene syndrome. Interv Neuroradiol. 2001;7(4):337–41.

    Article  CAS  PubMed  Google Scholar 

  37. Oyazato Y, Iijima K, Emi M, Sekine T, Kamei K, Takanashi J, et al. Molecular analysis of TSC2/PKD1 contiguous gene deletion syndrome. Kobe J Med Sci. 2011;57(1):E1–10.

    PubMed  Google Scholar 

  38. Boronat S, Shaaya EA, Auladell M, Thiele EA, Caruso P. Intracranial arteriopathy in tuberous sclerosis complex. J Child Neurol. 2014;29(7):912–9.

    Article  PubMed  Google Scholar 

  39. Schievink WI, Riedinger M, Maya MM. Frequency of incidental intracranial aneurysms in neurofibromatosis type 1. Am J Med Genet A. 2005;134A(1):45–8.

    Article  PubMed  Google Scholar 

  40. Kim ST, Brinjikji W, Kallmes DF. Prevalence of intracranial aneurysms in patients with connective tissue diseases: a retrospective study. AJNR Am J Neuroradiol. 2016;37:1422–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Schievink WI. Genetics of intracranial aneurysms. Neurosurgery. 1997;40(4):651–62; discussion 62–3.

    Article  CAS  PubMed  Google Scholar 

  42. Kim ST, Cloft H, Flemming KD, Kallmes DF, Lanzino G, Brinjikji W. Increased prevalence of cerebrovascular disease in hospitalized patients with Marfan syndrome. J Stroke Cerebrovasc Dis. 2018;27(2):296–300.

    Article  PubMed  Google Scholar 

  43. Kim ST, Cloft H, Flemming KD, Kallmes DF, Lanzino G, Brinjikji W. Increased prevalence of cerebrovascular disease in hospitalized patients with Ehlers-Danlos syndrome. J Stroke Cerebrovasc Dis. 2017;26(8):1678–82.

    Article  PubMed  Google Scholar 

  44. Schievink WI, Raissi SS, Maya MM, Velebir A. Screening for intracranial aneurysms in patients with bicuspid aortic valve. Neurology. 2010;74(18):1430–3.

    Article  PubMed  Google Scholar 

  45. Bober MB, Khan N, Kaplan J, Lewis K, Feinstein JA, Scott CI Jr, et al. Majewski osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype. Am J Med Genet A. 2010;152A(4):960–5.

    Article  PubMed  Google Scholar 

  46. Matsubara S, Mandzia JL, ter Brugge K, Willinsky RA, Faughnan ME. Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol. 2000;21(6):1016–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Furlan AJ, Whisnant JP, Elveback LR. The decreasing incidence of primary intracerebral hemorrhage: a population study. Ann Neurol. 1979;5(4):367–73.

    Article  CAS  PubMed  Google Scholar 

  48. Perret G, Nishioka H. Report on the cooperative study of intracranial aneurysms and subarachnoid hemorrhage. IV. Cerebral angiography. An analysis of the diagnostic value and complications of carotid and vertebral angiography in 5,484 patients. J Neurosurg. 1966;25(1):98–114.

    Article  CAS  PubMed  Google Scholar 

  49. Brown RD Jr, Wiebers DO, Torner JC, O’Fallon WM. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted Country, Minnesota. J Neurosurg. 1996;85(1):29–32.

    Article  PubMed  Google Scholar 

  50. Fleetwood IG, Steinberg GK. Arteriovenous malformations. Lancet. 2002;359(9309):863–73.

    Article  PubMed  Google Scholar 

  51. Stapf C, Mast H, Sciacca RR, Berenstein A, Nelson PK, Gobin YP, et al. The New York Islands AVM Study: design, study progress, and initial results. Stroke. 2003;34(5):e29–33.

    Article  CAS  PubMed  Google Scholar 

  52. Al-Shahi R, Bhattacharya JJ, Currie DG, Papanastassiou V, Ritchie V, Roberts RC, et al. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke. 2003;34(5):1163–9.

    Article  PubMed  Google Scholar 

  53. ApSimon HT, Reef H, Phadke RV, Popovic EA. A population-based study of brain arteriovenous malformation: long-term treatment outcomes. Stroke. 2002;33(12):2794–800.

    Article  CAS  PubMed  Google Scholar 

  54. Hofmeister C, Stapf C, Hartmann A, Sciacca RR, Mansmann U, terBrugge K, et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke. 2000;31(6):1307–10.

    Article  CAS  PubMed  Google Scholar 

  55. Berman MF, Sciacca RR, Pile-Spellman J, Stapf C, Connolly ES Jr, Mohr JP, et al. The epidemiology of brain arteriovenous malformations. Neurosurgery. 2000;47(2):389–96; discussion 97.

    Article  CAS  PubMed  Google Scholar 

  56. Brown RD Jr, Flemming KD, Meyer FB, Cloft HJ, Pollock BE, Link ML. Natural history, evaluation, and management of intracranial vascular malformations. Mayo Clin Proc. 2005;80(2):269–81.

    Article  PubMed  Google Scholar 

  57. Sibayan RQ. Management of non-traumatic subarachnoid hemorrhage in Filipinos. Neurol Med Chir (Tokyo). 1998;38(Suppl):124–7.

    Article  PubMed  Google Scholar 

  58. Kitkhuandee A, Thammaroj J, Munkong W, Duangthongpon P, Thanapaisal C. Cerebral angiographic findings in patients with non-traumatic subarachnoid hemorrhage. J Med Assoc Thail. 2012;95(Suppl 11):S121–9.

    Google Scholar 

  59. Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg. 1990;73(3):387–91.

    Article  CAS  PubMed  Google Scholar 

  60. Halim AX, Johnston SC, Singh V, McCulloch CE, Bennett JP, Achrol AS, et al. Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke. 2004;35(7):1697–702.

    Article  PubMed  Google Scholar 

  61. Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350–5.

    Article  CAS  PubMed  Google Scholar 

  62. da Costa L, Wallace MC, Ter Brugge KG, O’Kelly C, Willinsky RA, Tymianski M. The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke. 2009;40(1):100–5.

    Article  PubMed  Google Scholar 

  63. Mast H, Young WL, Koennecke HC, Sciacca RR, Osipov A, Pile-Spellman J, et al. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997;350(9084):1065–8.

    Article  CAS  PubMed  Google Scholar 

  64. Graf CJ, Perret GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg. 1983;58(3):331–7.

    Article  CAS  PubMed  Google Scholar 

  65. Forster DM, Steiner L, Hakanson S. Arteriovenous malformations of the brain. A long-term clinical study. J Neurosurg. 1972;37(5):562–70.

    Article  CAS  PubMed  Google Scholar 

  66. Padget DH. The cranial venous system in man in reference to development, adult configuration, and relation to the arteries. Am J Anat. 1956;98(3):307–55.

    Article  CAS  PubMed  Google Scholar 

  67. Stein BM, Wolpert SM. Arteriovenous malformations of the brain. I: current concepts and treatment. Arch Neurol. 1980;37(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  68. Gonzalez LF, Bristol RE, Porter RW, Spetzler RF. De novo presentation of an arteriovenous malformation. Case report and review of the literature. J Neurosurg. 2005;102(4):726–9.

    Article  PubMed  Google Scholar 

  69. Kader A, Goodrich JT, Sonstein WJ, Stein BM, Carmel PW, Michelsen WJ. Recurrent cerebral arteriovenous malformations after negative postoperative angiograms. J Neurosurg. 1996;85(1):14–8.

    Article  CAS  PubMed  Google Scholar 

  70. Morales-Valero SF, Bortolotti C, Sturiale C, Lanzino G. Are parenchymal AVMs congenital lesions? Neurosurg Focus. 2014;37(3):E2.

    Article  PubMed  Google Scholar 

  71. Lasjaunias P. A revised concept of the congenital nature of cerebral arteriovenous malformations. Interv Neuroradiol. 1997;3(4):275–81.

    Article  CAS  PubMed  Google Scholar 

  72. Kremer PH, Koeleman BP, Rinkel GJ, Diekstra FP, van den Berg LH, Veldink JH, et al. Susceptibility loci for sporadic brain arteriovenous malformation; a replication study and meta-analysis. J Neurol Neurosurg Psychiatry. 2015;87:693–6.

    Article  PubMed  Google Scholar 

  73. Kremer PH, Koeleman BP, Pawlikowska L, Weinsheimer S, Bendjilali N, Sidney S, et al. Evaluation of genetic risk loci for intracranial aneurysms in sporadic arteriovenous malformations of the brain. J Neurol Neurosurg Psychiatry. 2015;86(5):524–9.

    Article  CAS  PubMed  Google Scholar 

  74. Weinsheimer S, Bendjilali N, Nelson J, Guo DE, Zaroff JG, Sidney S, et al. Genome-wide association study of sporadic brain arteriovenous malformations. J Neurol Neurosurg Psychiatry. 2016;87(9):916–23.

    Article  PubMed  Google Scholar 

  75. Barbosa Do Prado L, Han C, Oh SP, Su H. Recent advances in basic research for brain arteriovenous malformation. Int J Mol Sci. 2019;20(21):5324.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91(1):66–7.

    Article  CAS  PubMed  Google Scholar 

  77. McDonald J, Wooderchak-Donahue W, VanSant WC, Whitehead K, Stevenson DA, Bayrak-Toydemir P. Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet. 2015;6:1.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Fulbright RK, Chaloupka JC, Putman CM, Sze GK, Merriam MM, Lee GK, et al. MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol. 1998;19(3):477–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Krings T, Kim H, Power S, Nelson J, Faughnan ME, Young WL, et al. Neurovascular manifestations in hereditary hemorrhagic telangiectasia: imaging features and genotype-phenotype correlations. AJNR Am J Neuroradiol. 2015;36(5):863–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Willemse RB, Mager JJ, Westermann CJ, Overtoom TT, Mauser H, Wolbers JG. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg. 2000;92(5):779–84.

    Article  CAS  PubMed  Google Scholar 

  81. Woodall MN, McGettigan M, Figueroa R, Gossage JR, Alleyne CH Jr. Cerebral vascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg. 2014;120(1):87–92.

    Article  PubMed  Google Scholar 

  82. Yang W, Liu A, Hung A, Braileanu M, Wang JY, Caplan JM, et al. Lower risk of intracranial arteriovenous malformation hemorrhage in patients with hereditary hemorrhagic telangiectasia. Neurosurgery. 2015;78:684–93.

    Article  Google Scholar 

  83. Krings T, Chng SM, Ozanne A, Alvarez H, Rodesch G, Lasjaunias PL. Hereditary haemorrhagic telangiectasia in children. Endovascular treatment of neurovascular malformations. Results in 31 patients. Interv Neuroradiol. 2005;11(1):13–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Krings T, Ozanne A, Chng SM, Alvarez H, Rodesch G, Lasjaunias PL. Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day-60 years. Neuroradiology. 2005;47(10):711–20.

    Article  CAS  PubMed  Google Scholar 

  85. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011;48(2):73–87.

    Article  CAS  PubMed  Google Scholar 

  86. Wooderchak-Donahue W, Stevenson DA, McDonald J, Grimmer JF, Gedge F, Bayrak-Toydemir P. RASA1 analysis: clinical and molecular findings in a series of consecutive cases. Eur J Med Genet. 2012;55(2):91–5.

    Article  PubMed  Google Scholar 

  87. Revencu N, Boon LM, Mulliken JB, Enjolras O, Cordisco MR, Burrows PE, et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat. 2008;29(7):959–65.

    Article  CAS  PubMed  Google Scholar 

  88. Thiex R, Mulliken JB, Revencu N, Boon LM, Burrows PE, Cordisco M, et al. A novel association between RASA1 mutations and spinal arteriovenous anomalies. AJNR Am J Neuroradiol. 2010;31(4):775–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Revencu N, Boon LM, Mendola A, Cordisco MR, Dubois J, Clapuyt P, et al. RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat. 2013;34(12):1632–41.

    Article  CAS  PubMed  Google Scholar 

  90. Grillner P, Soderman M, Holmin S, Rodesch G. A spectrum of intracranial vascular high-flow arteriovenous shunts in RASA1 mutations. Childs Nerv Syst. 2015;32:709–15.

    Article  PubMed  Google Scholar 

  91. Larralde M, Abad ME, Luna PC, Hoffner MV. Capillary malformation-arteriovenous malformation: a clinical review of 45 patients. Int J Dermatol. 2014;53(4):458–61.

    Article  PubMed  Google Scholar 

  92. Aoki Y, Niihori T, Inoue SI, Matsubara Y. Recent advances in RASopathies. J Hum Genet. 2015;61:33–9.

    Article  PubMed  Google Scholar 

  93. Bayrak-Toydemir P, Stevenson D. RASA1-related disorders. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews(R). Seattle, WA: University of Washington, Seattle; 1993.

    Google Scholar 

  94. Gray AM. Haemangiectatic hypertrophy (Parkes Weber). Proc R Soc Med. 1928;21(8):1431–2.

    PubMed  PubMed Central  Google Scholar 

  95. Boon LM, Mulliken JB, Vikkula M. RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev. 2005;15(3):265–9.

    Article  CAS  PubMed  Google Scholar 

  96. Namba K, Nemoto S. Parkes Weber syndrome and spinal arteriovenous malformations. AJNR Am J Neuroradiol. 2013;34(9):E110–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Matsumaru Y, Pongpech S, Laothamas J, Alvarez H, Rodesch G, Lasjaunias P. Multifocal and metameric spinal cord arteriovenous malformations. Review of 19 cases. Interv Neuroradiol. 1999;5(1):27–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Niimi Y, Ito U, Tone O, Yoshida K, Sato S, Berenstein A. Multiple spinal perimedullary arteriovenous fistulae associated with the Parkes-Weber syndrome. A case report. Interv Neuroradiol. 1998;4(2):151–7.

    Article  CAS  PubMed  Google Scholar 

  99. Tan WH, Baris HN, Burrows PE, Robson CD, Alomari AI, Mulliken JB, et al. The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet. 2007;44(9):594–602.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Naidich JJ, Rofsky NM, Rosen R, Karp N. Arteriovenous malformation in a patient with Bannayan–Zonana syndrome. Clin Imaging. 2001;25(2):130–2.

    Article  CAS  PubMed  Google Scholar 

  101. Alomari AI, Chaudry G, Rodesch G, Burrows PE, Mulliken JB, Smith ER, et al. Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: analysis of clinical and imaging findings in 6 patients. AJNR Am J Neuroradiol. 2011;32(10):1812–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Gopal B, Keshava SN, Selvaraj D. A rare newly described overgrowth syndrome with vascular malformations-Cloves syndrome. Indian J Radiol Imaging. 2015;25(1):71–3.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Rohany M, Shaibani A, Arafat O, Walker MT, Russell EJ, Batjer HH, et al. Spinal arteriovenous malformations associated with Klippel-Trenaunay-Weber syndrome: a literature search and report of two cases. AJNR Am J Neuroradiol. 2007;28(3):584–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  104. Sgubin D, Kanai R, Di Paola F, Perin A, Longatti P. Conus medullaris-cauda arteriovenous malformation and Klippel-Trenaunay syndrome: what is the treatment goal? Neurol Med Chir (Tokyo). 2013;53(2):110–4.

    Article  PubMed  Google Scholar 

  105. Chen D, Li L, Tu X, Yin Z, Wang Q. Functional characterization of Klippel-Trenaunay syndrome gene AGGF1 identifies a novel angiogenic signaling pathway for specification of vein differentiation and angiogenesis during embryogenesis. Hum Mol Genet. 2013;22(5):963–76.

    Article  CAS  PubMed  Google Scholar 

  106. Tian XL, Kadaba R, You SA, Liu M, Timur AA, Yang L, et al. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature. 2004;427(6975):640–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Giombini S, Morello G. Cavernous angiomas of the brain. Account of fourteen personal cases and review of the literature. Acta Neurochir. 1978;40(1–2):61–82.

    Article  CAS  PubMed  Google Scholar 

  108. Rigamonti D, Hadley MN, Drayer BP, Johnson PC, Hoenig-Rigamonti K, Knight JT, et al. Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med. 1988;319(6):343–7.

    Article  CAS  PubMed  Google Scholar 

  109. Otten P, Pizzolato GP, Rilliet B, Berney J. [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies]. Neurochirurgie. 1989;35(2):82–3, 128–31.

    Google Scholar 

  110. Kim DS, Park YG, Choi JU, Chung SS, Lee KC. An analysis of the natural history of cavernous malformations. Surg Neurol. 1997;48(1):9–17; discussion 8.

    Article  CAS  PubMed  Google Scholar 

  111. Del Curling O Jr, Kelly DL Jr, Elster AD, Craven TE. An analysis of the natural history of cavernous angiomas. J Neurosurg. 1991;75(5):702–8.

    Article  PubMed  Google Scholar 

  112. Sage MR, Brophy BP, Sweeney C, Phipps S, Perrett LV, Sandhu A, et al. Cavernous haemangiomas (angiomas) of the brain: clinically significant lesions. Australas Radiol. 1993;37(2):147–55.

    Article  CAS  PubMed  Google Scholar 

  113. Zabramski JM, Wascher TM, Spetzler RF, Johnson B, Golfinos J, Drayer BP, et al. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 1994;80(3):422–32.

    Article  CAS  PubMed  Google Scholar 

  114. Leblanc GG, Golanov E, Awad IA, Young WL. Biology of vascular malformations of the brain. Stroke. 2009;40(12):e694–702.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Nikoubashman O, Di Rocco F, Davagnanam I, Mankad K, Zerah M, Wiesmann M. Prospective hemorrhage rates of cerebral cavernous malformations in children and adolescents based on MRI appearance. AJNR Am J Neuroradiol. 2015;36(11):2177–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Al-Shahi Salman R, Hall JM, Horne MA, Moultrie F, Josephson CB, Bhattacharya JJ, et al. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol. 2012;11(3):217–24.

    Article  PubMed  Google Scholar 

  117. Wang CC, Liu A, Zhang JT, Sun B, Zhao YL. Surgical management of brain-stem cavernous malformations: report of 137 cases. Surg Neurol. 2003;59(6):444–54; discussion 54.

    Article  PubMed  Google Scholar 

  118. Aiba T, Tanaka R, Koike T, Kameyama S, Takeda N, Komata T. Natural history of intracranial cavernous malformations. J Neurosurg. 1995;83(1):56–9.

    Article  CAS  PubMed  Google Scholar 

  119. Kondziolka D, Lunsford LD, Kestle JR. The natural history of cerebral cavernous malformations. J Neurosurg. 1995;83(5):820–4.

    Article  CAS  PubMed  Google Scholar 

  120. Porter PJ, Willinsky RA, Harper W, Wallace MC. Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg. 1997;87(2):190–7.

    Article  CAS  PubMed  Google Scholar 

  121. Horne MA, Flemming KD, Su IC, Stapf C, Jeon JP, Li D, et al. Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol. 2016;15(2):166–73.

    Article  PubMed  PubMed Central  Google Scholar 

  122. Dashti SR, Hoffer A, Hu YC, Selman WR. Molecular genetics of familial cerebral cavernous malformations. Neurosurg Focus. 2006;21(1):e2.

    Article  PubMed  Google Scholar 

  123. Hayman LA, Evans RA, Ferrell RE, Fahr LM, Ostrow P, Riccardi VM. Familial cavernous angiomas: natural history and genetic study over a 5-year period. Am J Med Genet. 1982;11(2):147–60.

    Article  CAS  PubMed  Google Scholar 

  124. Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. Genetics of cavernous angiomas. Lancet Neurol. 2007;6(3):237–44.

    Article  CAS  PubMed  Google Scholar 

  125. Petersen TA, Morrison LA, Schrader RM, Hart BL. Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype. AJNR Am J Neuroradiol. 2010;31(2):377–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Shenkar R, Shi C, Rebeiz T, Stockton RA, McDonald DA, Mikati AG, et al. Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genet Med. 2015;17(3):188–96.

    Article  CAS  PubMed  Google Scholar 

  127. Maraire JN, Awad IA. Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery. 1995;37(4):591–605.

    Article  CAS  PubMed  Google Scholar 

  128. Tekkok IH, Ventureyra EC. De novo familial cavernous malformation presenting with hemorrhage 12.5 years after the initial hemorrhagic ictus: natural history of an infantile form. Pediatr Neurosurg. 1996;25(3):151–5.

    Article  CAS  PubMed  Google Scholar 

  129. Detwiler PW, Porter RW, Zabramski JM, Spetzler RF. De novo formation of a central nervous system cavernous malformation: implications for predicting risk of hemorrhage. Case report and review of the literature. J Neurosurg. 1997;87(4):629–32.

    Article  CAS  PubMed  Google Scholar 

  130. Larson JJ, Ball WS, Bove KE, Crone KR, Tew JM Jr. Formation of intracerebral cavernous malformations after radiation treatment for central nervous system neoplasia in children. J Neurosurg. 1998;88(1):51–6.

    Article  CAS  PubMed  Google Scholar 

  131. Chang SD, Vanefsky MA, Havton LA, Silverberg GD. Bilateral cavernous malformations resulting from cranial irradiation of a choroid plexus papilloma. Neurol Res. 1998;20(6):529–32.

    Article  CAS  PubMed  Google Scholar 

  132. Ogilvy CS, Moayeri N, Golden JA. Appearance of a cavernous hemangioma in the cerebral cortex after a biopsy of a deeper lesion. Neurosurgery. 1993;33(2):307–9; discussion 9.

    Article  CAS  PubMed  Google Scholar 

  133. Ciricillo SF, Dillon WP, Fink ME, Edwards MS. Progression of multiple cryptic vascular malformations associated with anomalous venous drainage. Case report. J Neurosurg. 1994;81(3):477–81.

    Article  CAS  PubMed  Google Scholar 

  134. Revencu N, Vikkula M. Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet. 2006;43(9):716–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Zawistowski JS, Serebriiskii IG, Lee MF, Golemis EA, Marchuk DA. KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum Mol Genet. 2002;11(4):389–96.

    Article  CAS  PubMed  Google Scholar 

  136. Zhang J, Rigamonti D, Dietz HC, Clatterbuck RE. Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations. Neurosurgery. 2007;60(2):353–9; discussion 9.

    Article  PubMed  Google Scholar 

  137. D’Angelo R, Marini V, Rinaldi C, Origone P, Dorcaratto A, Avolio M, et al. Mutation analysis of CCM1, CCM2 and CCM3 genes in a cohort of Italian patients with cerebral cavernous malformation. Brain Pathol. 2011;21(2):215–24.

    Article  PubMed  Google Scholar 

  138. Denier C, Labauge P, Bergametti F, Marchelli F, Riant F, Arnoult M, et al. Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann Neurol. 2006;60(5):550–6.

    Article  PubMed  Google Scholar 

  139. Davenport WJ, Siegel AM, Dichgans J, Drigo P, Mammi I, Pereda P, et al. CCM1 gene mutations in families segregating cerebral cavernous malformations. Neurology. 2001;56(4):540–3.

    Article  CAS  PubMed  Google Scholar 

  140. Craig HD, Gunel M, Cepeda O, Johnson EW, Ptacek L, Steinberg GK, et al. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet. 1998;7(12):1851–8.

    Article  CAS  PubMed  Google Scholar 

  141. Gunel M, Awad IA, Anson J, Lifton RP. Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A. 1995;92(14):6620–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  142. Mindea SA, Yang BP, Shenkar R, Bendok B, Batjer HH, Awad IA. Cerebral cavernous malformations: clinical insights from genetic studies. Neurosurg Focus. 2006;21(1):e1.

    Article  PubMed  Google Scholar 

  143. Riant F, Cecillon M, Saugier-Veber P, Tournier-Lasserve E. CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletions. Neurogenetics. 2013;14(2):133–41.

    Article  CAS  PubMed  Google Scholar 

  144. Spiegler S, Najm J, Liu J, Gkalympoudis S, Schroder W, Borck G, et al. High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one-third of probands are minors. Mol Genet Genomic Med. 2014;2(2):176–85.

    Article  PubMed  PubMed Central  Google Scholar 

  145. Liquori CL, Berg MJ, Squitieri F, Leedom TP, Ptacek L, Johnson EW, et al. Deletions in CCM2 are a common cause of cerebral cavernous malformations. Am J Hum Genet. 2007;80(1):69–75.

    Article  CAS  PubMed  Google Scholar 

  146. Liquori CL, Berg MJ, Squitieri F, Ottenbacher M, Sorlie M, Leedom TP, et al. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus. Hum Mutat. 2006;27(1):118.

    Article  PubMed  Google Scholar 

  147. Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A, et al. Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet. 2004;74(2):326–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  148. Chen L, Tanriover G, Yano H, Friedlander R, Louvi A, Gunel M. Apoptotic functions of PDCD10/CCM3, the gene mutated in cerebral cavernous malformation 3. Stroke. 2009;40(4):1474–81.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Schleider E, Stahl S, Wustehube J, Walter U, Fischer A, Felbor U. Evidence for anti-angiogenic and pro-survival functions of the cerebral cavernous malformation protein 3. Neurogenetics. 2011;12(1):83–6.

    Article  CAS  PubMed  Google Scholar 

  150. Zhu Y, Wu Q, Xu JF, Miller D, Sandalcioglu IE, Zhang JM, et al. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations. Neurosurg Focus. 2010;29(3):E1.

    Article  PubMed  Google Scholar 

  151. Riant F, Bergametti F, Fournier HD, Chapon F, Michalak-Provost S, Cecillon M, et al. CCM3 mutations are associated with early-onset cerebral hemorrhage and multiple meningiomas. Mol Syndromol. 2013;4(4):165–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  152. Garaci F, Marsili L, Riant F, Marziali S, Cecillon M, Pasquarelli R, et al. Cerebral cavernous malformations associated to meningioma: high penetrance in a novel family mutated in the PDCD10 gene. Neuroradiol J. 2015;28(3):289–93.

    Article  PubMed  PubMed Central  Google Scholar 

  153. Gianfrancesco F, Esposito T, Penco S, Maglione V, Liquori CL, Patrosso MC, et al. ZPLD1 gene is disrupted in a patient with balanced translocation that exhibits cerebral cavernous malformations. Neuroscience. 2008;155(2):345–9.

    Article  CAS  PubMed  Google Scholar 

  154. Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson GL, et al. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet. 2005;14(17):2521–31.

    Article  CAS  PubMed  Google Scholar 

  155. Chan AC, Drakos SG, Ruiz OE, Smith AC, Gibson CC, Ling J, et al. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J Clin Invest. 2011;121(5):1871–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  156. Yoruk B, Gillers BS, Chi NC, Scott IC. CCM3 functions in a manner distinct from CCM1 and CCM2 in a zebrafish model of CCM vascular disease. Dev Biol. 2012;362(2):121–31.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Mayo Clinic, Rochester, MN, USA

    Deena M. Nasr, Jennifer Fugate & Robert D. Brown Jr

Authors
  1. Deena M. Nasr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Fugate
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert D. Brown Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Deena M. Nasr .

Editor information

Editors and Affiliations

  1. Royal Holloway University of London, Egham, Greater London, UK

    Pankaj Sharma

  2. Dept of Neurology, Mayo Clinic, Jacksonville, FL, USA

    James F. Meschia

Rights and permissions

Reprints and permissions

Copyright information

© 2024 Mayo Clinic, The Editor(s) and The Author(s), under exclusive licence to Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nasr, D.M., Fugate, J., Brown, R.D. (2024). The Genetics of Cerebral Aneurysms and Other Vascular Malformations. In: Sharma, P., Meschia, J.F. (eds) Stroke Genetics. Springer, Cham. https://doi.org/10.1007/978-3-031-41777-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-41777-1_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-41776-4

  • Online ISBN: 978-3-031-41777-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation